| Literature DB >> 26782852 |
Annika Toots1,2, Håkan Littbrand1,2, Nina Lindelöf1,2, Robert Wiklund1,2, Henrik Holmberg3, Peter Nordström2, Lillemor Lundin-Olsson1, Yngve Gustafson2, Erik Rosendahl1,2.
Abstract
OBJECTIVES: To investigate the effects of a high-intensity functional exercise program on independence in activities of daily living (ADLs) and balance in older people with dementia and whether exercise effects differed between dementia types.Entities:
Keywords: activities of daily living; dementia; exercise; postural balance; residential facilities
Mesh:
Year: 2016 PMID: 26782852 PMCID: PMC4722852 DOI: 10.1111/jgs.13880
Source DB: PubMed Journal: J Am Geriatr Soc ISSN: 0002-8614 Impact factor: 5.562
Figure 1Flow of participants through the study. Recruitment and baseline assessment were performed in August and September 2011, interventions were implemented between October 2011 and February 2012, first follow-up assessments were performed in March–April 2012, and last follow-up assessments were performed in May and June 2012. ADLs = activities of daily living; MMSE = Mini-Mental State Examination; SD=standard deviation.
Characteristics of the Study Population and Baseline Outcome Measures
| Characteristic | Total, N = 186 | Exercise, n = 93 | Control, n = 93 | AD, n = 67 | Non-AD, n = 119 |
|---|---|---|---|---|---|
| Age, mean ± SD | 85.1 ± 7.1 | 84.4 ± 6.2 | 85.9 ± 7.8 | 85.5 ± 6.1 | 88.9 ± 7.6 |
| Female, n (%) | 141 (75.8) | 70 (75.3) | 71 (76.3) | 53 (79.1) | 88 (73.9) |
| Dementia type, n (%) | |||||
| Vascular | 77 (41.4) | 36 (38.7) | 41 (44.1) | ||
| Alzheimer's disease | 67 (36.0) | 34 (36.6) | 33 (35.5) | ||
| Other | 27 (14.5) | 15 (16.1) | 12 (12.9) | ||
| Mixed Alzheimer's disease and vascular | 15 (8.1) | 8 (8.6) | 7 (7.5) | ||
| Diagnoses and medical conditions, n (%) | |||||
| Depressive disorder | 107 (57.5) | 53 (57.0) | 54 (58.1) | 40 (59.7) | 67 (56.3) |
| Delirium previous week | 102 (54.8) | 48 (51.6) | 54 (58.1) | 37 (55.2) | 65 (54.6) |
| Previous stroke | 57 (30.6) | 33 (35.5) | 24 (25.8) | 5 (7.5) | 52 (43.7) |
| Heart failure | 56 (30.1) | 24 (25.8) | 32 (34.4) | 15 (22.4) | 41 (34.5) |
| Previous hip fracture | 53 (28.5) | 28 (30.1) | 25 (26.9) | 11 (16.4) | 42 (35.3) |
| Angina pectoris | 49 (26.3) | 21 (22.6) | 28 (30.1) | 13 (19.4) | 36 (30.3) |
| Diabetes mellitus | 29 (15.6) | 18 (19.4) | 11 (11.8) | 9 (13.4) | 20 (16.8) |
| Prescription medication, n (%) | |||||
| Analgesics | 112 (60.2) | 55 (59.1) | 57 (61.3) | 42 (62.7) | 70 (58.8) |
| Antidepressants | 102 (54.8) | 58 (62.4) | 44 (47.3) | 43 (64.2) | 59 (49.6) |
| Diuretics | 88 (47.3) | 41 (44.1) | 47 (50.5) | 26 (43.3) | 59 (49.6) |
| Vitamin D–calcium supplement | 60 (32.3) | 32 (34.4) | 28 (30.1) | 16 (23.9) | 44 (37.0) |
| Cholinesterase inhibitor | 40 (21.5) | 25 (26.9) | 15 (16.1) | 26 (38.3) | 14 (11.8) |
| Benzodiazepine | 40 (21.5) | 19 (20.4) | 21 (22.6) | 18 (26.9) | 22 (18.5) |
| Neuroleptic | 31 (16.7) | 11 (11.8) | 20 (21.5) | 12 (17.9) | 19 (16.0) |
| Memantine | 12 (6.5) | 7 (7.5) | 5 (5.4) | 11 (16.4) | 1 (0.8) |
| Number of medications, mean±SD | 8.3 (3.8) | 8.4 (4.0) | 8.2 (3.7) | 7.5 (3.3) | 8.8 (4.1) |
| Blood test results | |||||
| Vitamin D ≤ 50 nmol/L, n = 161 | 83 (51.6) | 37 (50.0) | 46 (52.9) | 33 (49.3) | 50 (42.0) |
| Parathyroid hormone > 6.9 pmol/L, n = 161 | 42 (26.1) | 16 (21.9) | 26 (29.5) | 14 (20.9) | 28 (23.5) |
| Creatinine clearance ≤30 ml/min, n = 152 | 17 (11.2) | 5 (7.2) | 12 (14.5) | 3 (4.5) | 14 (11.8) |
| Assessments | |||||
| Gait speed over 4 m, m/s, mean±SD (range), n = 185 | 0.45 ± 0.2 (0.01–1.16) | 0.45 ± 0.2 (0.01–1.13) | 0.45 ± 0.2 (0.01–0.16) | 0.51 ± 0.2 (0.01–1.16) | 0.41 ± 0.2 (0.01–0.93) |
| Pain when walking, n (%), n = 185 | 35 (18.9) | 15 (16.3) | 20 (21.5) | 15 (22.4) | 20 (16.8) |
| Mini-Mental State Examination score, mean±SD (range 0–30) | 14.9 ± 3.5 | 15.4 ± 3.4 | 14.4 ± 3.5 | 14.0 ± 3.1 | 15.4 ± 3.6 |
| 15-item Geriatric Depression Scale score, mean±SD (range 0–15), n = 183 | 3.8 ± 3.2 | 4.0 ± 3.4 | 3.6 ± 2.9 | 3.1 ± 3.1 | 4.1 ± 3.1 |
| Neuropsychiatric Inventory, mean±SD (range 0–144) | 14.8 ± 14.2 | 15.2 ± 15.8 | 14.4 ± 12.6 | 16.7 ± 13.2 | 13.7 ± 14.7 |
| Mini Nutritional Assessment, mean±SD (range 0–30), n = 185 | 21.1 ± 2.7 | 21.3 ± 2.8 | 20.9 ± 2.6 | 21.1 ± 2.8 | 21.1 ± 2.6 |
| Vision impairment | 26 (14.0) | 10 (10.8) | 16 (17.2) | 16 (23.9) | 10 (8.4) |
| Self-reported health; good, very good, excellent | 119 (64.0) | 60 (64.5) | 59 (63.4) | 43 (64.2) | 76 (63.9) |
| Functional Independence Measure, mean±SD (range 13–91) | 52.0 ± 16.9 | 51.6 ± 17.1 | 52.5 ± 16.7 | 53.2 ± 16.7 | 51.4 ± 17.0 |
| Barthel Index, mean± SD (range 0–20) | 10.9 ± 4.4 | 10.7 ± 4.5 | 11.0 ± 4.4 | 11.1 ± 4.3 | 10.7 ± 4.5 |
| Berg Balance Scale, mean±SD (range 0–56) | 28.9 ± 14.5 | 28.6 ± 14.3 | 29.3 ± 14.7 | 33.0 ± 13.7 | 26.7 ± 14.4 |
Numbers reported after covariates indicate number of measurements available when values were missing.
Missing data were imputed to 0.01 m/s when participants were unable to complete the gait speed test because of physical impairment.
Higher scores indicate better status.
Lower scores indicate better status.
When at least 10 Geriatric Depression Scale (GDS-15) questions were answered, missing data were imputed using the mean score of questions answered.
Unable to read words printed in 5-mm capital letters, with or without glasses, at a normal reading distance.
AD = Alzheimer's disease; SD = standard deviation; Non-AD = vascular dementia, mixed AD and vascular dementia, and all other types of dementia.
Within- and Between-Group Differences from Baseline in the Functional Independence Measure (FIM), Barthel Index of Activities of Daily Living, and Berg Balance Scale (BBS)
| Measure | Within-Group Difference | Between-Group Difference | Intracluster Correlation Coefficient | ||||
|---|---|---|---|---|---|---|---|
| N | Exercise, Mean (SE) | N | Control, Mean (SE) | Mean (95% Confidence Interval) | |||
| FIM | |||||||
| 4 months | 83 | −3.10 (1.07) | 88 | −4.44 (1.04) | 1.34 (−1.56–4.25) | .36 | 0.04 |
| 7 months | 79 | −6.77 (1.09) | 79 | −7.55 (1.08) | 0.78 (−2.21–3.77) | .61 | |
| Barthel Index | |||||||
| 4 months | 83 | −0.79 (0.31) | 88 | −1.39 (0.30) | 0.60 (−0.24–1.44) | .16 | 0.05 |
| 7 months | 79 | −1.56 (0.32) | 79 | −2.12 (0.32) | 0.57 (−0.30–1.43) | .20 | |
| BBS | |||||||
| 4 months | 81 | 2.39 (0.88) | 86 | −1.82 (0.86) | 4.20 (1.79–6.61) | <.001 | 0.07 |
| 7 months | 74 | −2.08 (0.91) | 75 | −2.05 (0.90) | −0.02 (−2.53–2.49) | .98 | |
Based on proportion of variation explained by cluster.
From linear mixed-effects models of the complete sample (N = 186) adjusted for age, sex, and antidepressant use.
SE = standard error.
Figure 2Changes in Functional Independence Measure, Barthel Index of activities of daily living (ADLs), and Berg Balance Scale (A–C) and according to dementia type (D–F). Values are least square means of changes from baseline, with 95% confidence intervals, from linear mixed-effects models of the complete sample (n = 186) adjusted for age, sex, and antidepressant use. Non-AD dementia included vascular dementia, mixed Alzheimer's disease (AD) and vascular dementia, and all other types of non-Alzheimer's dementia. ES = effect size.
Within-Group Differences from Baseline in the Functional Independence Measure (FIM), Barthel Index of Activities of Daily Living, and Berg Balance Scale (BBS), and Differences in Exercise Effect According to Dementia Type
| Measure | Within-Group Difference | Interaction | ||||
|---|---|---|---|---|---|---|
| N | Exercise, Mean (SE) | N | Control, Mean (SE) | Mean (95% Confidence Interval) | ||
| FIM | ||||||
| 4 months | ||||||
| AD | 30 | −2.97 (1.77) | 33 | −3.67 (1.69) | 1.04 (−4.98–7.04) | .74 |
| Non-AD | 53 | −3.18 (1.33) | 55 | −4.91 (1.30) | ||
| 7 months | ||||||
| AD | 29 | −9.14 (1.79) | 29 | −5.33 (1.77) | 7.28 (1.10–13.47) | .02 |
| Non-AD | 50 | −5.40 (1.36) | 50 | −8.86 (1.35) | ||
| Barthel Index | ||||||
| 4 months | ||||||
| AD | 30 | −1.01 (0.51) | 33 | −0.85 (0.49) | 1.21 (−0.53–2.95) | .17 |
| Non-AD | 53 | −0.66 (0.39) | 55 | −1.71 (0.38) | ||
| 7 months | ||||||
| AD | 29 | −2.13 (0.52) | 29 | −1.22 (0.52) | 2.34 (0.55–4.13) | .01 |
| Non-AD | 50 | −1.23 (0.40) | 50 | −2.65 (0.39) | ||
| BBS | ||||||
| 4 months | ||||||
| AD | 30 | −0.44 (1.44) | 33 | −1.34 (1.38) | 5.26 (0.35–10.18) | .04 |
| Non-AD | 51 | 4.02 (1.10) | 53 | −2.14 (1.08) | ||
| 7 months | ||||||
| AD | 27 | −5.33 (1.49) | 27 | −1.15 (1.48) | 6.57 (1.4–11.73) | .01 |
| Non-AD | 47 | −0.21 (1.13) | 48 | −2.59 (1.12) | ||
Difference in exercise effect between participants with Alzheimer's disease (AD) and those with non-AD dementia. A positive mean value indicates a greater effect in favor of participants with non-AD dementia.
From linear mixed effects models of the complete sample (n = 186) adjusted for age, sex, and antidepressant use as fixed effects.
SE = standard error; non-AD = vascular dementia, mixed AD and vascular dementia, and all other types of dementia.